Nectin Therapeutics

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.

Neogene Therapeutics

This biotechnology company develops engineered T cell receptor therapies targeting neoantigens in solid cancers for patients with oncology needs.

Pionyr Immunotherapeutics

This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

Nextera

This company develops antibody therapies and drug targets for pharmaceutical organisations treating cancer, autoimmunity and inflammatory diseases.

Tacalyx

This company develops antibody-based therapeutics targeting tumour associated carbohydrate antigens for the treatment of solid tumours in cancer patients.

cCAM Biotherapeutics

The company develops monoclonal antibody immunotherapies to treat cancer patients with advanced or recurrent malignancies.

Neobe

The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.